BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230303T080000
DTEND;TZID=America/New_York:20230316T170000
DTSTAMP:20260403T180220
CREATED:20230131T180509Z
LAST-MODIFIED:20230131T180509Z
UID:7234-1677830400-1678986000@carb-x.org
SUMMARY:An Unfinished Life: The True Impact of Antibiotic Resistance
DESCRIPTION:Join Australia’s mission against superbugs with the Australian Premiere of Salt in my Soul followed by an interactive discussion forum with the scientists\, clinicians and policy makers working at the coalface of antimicrobial resistance. \nSpeakers include CARB-X’s Chief Scientist\, Dr. Richard Alm \nMarch 3rd: Perth \nMarch 7th: Brisbane \nMarch 10th: Adelaide \nMarch 14th: Melbourne \nMarch 16th: Sydney
URL:https://carb-x.org/event/an-unfinished-life-the-true-impact-of-antibiotic-resistance/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230316T080000
DTEND;TZID=America/New_York:20230317T170000
DTSTAMP:20260403T180220
CREATED:20221101T210819Z
LAST-MODIFIED:20221101T210819Z
UID:6952-1678953600-1679072400@carb-x.org
SUMMARY:7th AMR Conference
DESCRIPTION:The #AMRconference is a platform for SMEs\, start-ups\, big pharma\, academia\, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. \nThe “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business\, science\, clinics\, finance\, regulatory affairs and intellectual property. \n\n\n\n\n\n\n\n\n\n\n\n\nThe BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015\, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong network of more than 60 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. The aim is to establish the AMR Conference as the one-stop-shop in Europe to meet all AMR relevant stakeholders.
URL:https://carb-x.org/event/7th-amr-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230415T080000
DTEND;TZID=America/New_York:20230418T170000
DTSTAMP:20260403T180220
CREATED:20221101T211019Z
LAST-MODIFIED:20221101T211039Z
UID:6954-1681545600-1681837200@carb-x.org
SUMMARY:ECCMID 2023
DESCRIPTION:ECCMID invites you to the 33rd European Congress of Clinical Microbiology & Infectious Diseases\, which will take place as a hybrid event both online and in Copenhagen\, Denmark on 15 – 18 April 2023.
URL:https://carb-x.org/event/eccmid-2023/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230420T180000
DTEND;TZID=America/New_York:20230420T190000
DTSTAMP:20260403T180220
CREATED:20230301T184621Z
LAST-MODIFIED:20230301T185709Z
UID:7283-1682013600-1682017200@carb-x.org
SUMMARY:CARB-X Funding Rounds Q&A #1
DESCRIPTION:Register here for the 1st of 2 Q&A sessions on the upcoming CARB-X funding rounds.
URL:https://carb-x.org/event/carb-x-funding-rounds-qa-1-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230421T080000
DTEND;TZID=America/New_York:20230421T090000
DTSTAMP:20260403T180220
CREATED:20230301T185258Z
LAST-MODIFIED:20230301T185634Z
UID:7285-1682064000-1682067600@carb-x.org
SUMMARY:CARB-X Funding Rounds Q&A #2
DESCRIPTION:Register here for the 2nd of 2 Q&A sessions on the upcoming CARB-X funding rounds.
URL:https://carb-x.org/event/carb-x-funding-rounds-qa-2-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230517T133500
DTEND;TZID=America/New_York:20230517T142000
DTSTAMP:20260403T180220
CREATED:20230502T182906Z
LAST-MODIFIED:20230502T182906Z
UID:7546-1684330500-1684333200@carb-x.org
SUMMARY:Financial Times Live Panel: National health security – Addressing rising threats
DESCRIPTION:The coronavirus pandemic was a wake-up call for those inclined to ignore emerging health threats. Looking to the future\, whether it be another virus\, mental health\, or noncommunicable diseases such as diabetes and dementia\, the US must consider its options to avoid or at least minimize the impact of health threats with the potential to cause even more pain if ignored. \n\nHow can stakeholders work together to prepare for epidemics and pandemics of the future?\nWhat can be done to support health systems in handling the rise of chronic conditions such as obesity and dementia?\nWhat advances are we seeing in treatment of increasingly prevalent conditions such as Alzheimer’s\, diabetes and cancer?\nAs recognition and understanding of mental health evolves\, how could treatments change?\n\nSpeakers: \nKevin Outterson\, Austin B. Fletcher Professor\, Boston University\, Executive Director and Principal Investigator\, CARB-X \nRasmus Besch Hansen\, CEO and Founder\, Airfinity \nOlivier Bogillot\, Head of US General Medicines\, Sanofi \nJulie Gerberding\, CEO\, Foundation for the National Institutes of Health \nAndrew Jack\, Global Education Editor\, Financial Times
URL:https://carb-x.org/event/financial-times-live-panel-national-health-security-addressing-rising-threats/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230518T080000
DTEND;TZID=America/New_York:20230519T170000
DTSTAMP:20260403T180220
CREATED:20230419T192936Z
LAST-MODIFIED:20230419T192936Z
UID:7456-1684396800-1684515600@carb-x.org
SUMMARY:BSAC Spring Conference
DESCRIPTION:ADDRESSING THE AMR BURDEN IN EVERYDAY PRACTICE
URL:https://carb-x.org/event/bsac-spring-conference-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230521T080000
DTEND;TZID=America/New_York:20230530T170000
DTSTAMP:20260403T180220
CREATED:20221214T152058Z
LAST-MODIFIED:20221214T152058Z
UID:7105-1684656000-1685466000@carb-x.org
SUMMARY:76th World Health Assembly
DESCRIPTION:The World Health Assembly is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board. The main functions of the World Health Assembly are to determine the policies of the Organization\, appoint the Director-General\, supervise financial policies\, and review and approve the proposed programme budget. The Health Assembly is held annually in Geneva\, Switzerland.
URL:https://carb-x.org/event/76th-world-health-assembly/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230605T080000
DTEND;TZID=America/New_York:20230608T170000
DTSTAMP:20260403T180220
CREATED:20230419T193118Z
LAST-MODIFIED:20230419T193118Z
UID:7458-1685952000-1686243600@carb-x.org
SUMMARY:BIO Boston 2023
DESCRIPTION:Stand up for innovation. Stand up for truth. And stand up for science. It’s time to inspire\, honor\, and recognize the true value of the breakthrough work biotech performs for society. Today. And every day. Well into the future.
URL:https://carb-x.org/event/bio-boston-2023/
LOCATION:Boston Convention Center\, 415 Summer St\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20230610T150000
DTEND;TZID=Asia/Kolkata:20230610T173000
DTSTAMP:20260403T180220
CREATED:20230522T134117Z
LAST-MODIFIED:20230522T134117Z
UID:7583-1686409200-1686418200@carb-x.org
SUMMARY:Engaging the Pharmaceutical Industry in Joint Efforts to Tackle ANTIMICROBIAL RESISTANCE
DESCRIPTION:A webinar focused on AMR issues pertinent to India such as: \n\nWhat is the current status of antibiotic development in the pipeline\, both in India and globally?\nWhat are some potential strategies or incentives to stimulate anti-infective development in India?\nWhat role can the Indian pharmaceutical industry play in global efforts to develop new anti-infectives?\nHow can we ensure the availability and affordability of new antibiotics in India while maintaining their responsible use?\n\nRegister here to join the conversation.
URL:https://carb-x.org/event/engaging-the-pharmaceutical-industry-in-joint-efforts-to-tackle-antimicrobial-resistance/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230612T080000
DTEND;TZID=America/New_York:20230613T170000
DTSTAMP:20260403T180220
CREATED:20230419T193241Z
LAST-MODIFIED:20230419T193241Z
UID:7460-1686556800-1686675600@carb-x.org
SUMMARY:Boston Bacterial Meeting 2023
DESCRIPTION:The meeting will be held at the Harvard Science Center\, 1 Oxford St\, Cambridge\, MA 02138. Please visit our Directions page for information on public transit and parking. \n\n\n\n\nThe keynote address for BBM 2023 will be delivered by Dr. Kumaran Ramamurthi from the NIH. Dr. Ramamurthi is a renowned bacterial cell biologist who has made important contributions to our understanding of how morphogenetic proteins localize to specific sites and drive essential processes such as spore formation and cell division. Please visit our Keynote Speaker page for more information about his career and accomplishments. \n\n\n\n\n\n\n\n\n\n\n\nAbout BBM\n\n\n\n\nBBM was founded in 1995 by two postdocs from Richard Losick’s lab at Harvard\, Kit Pogliano and Karen McGovern\, with the goal of bringing bacteriologists from the greater Boston area together to present their work and share ideas. BBM\, now in its 29th year\, has proven to be a vibrant meeting\, attended not only by bacteriologists from the Boston area but from all over the country. Keeping with its roots\, the conference is being planned and organized by a committee of students\, postdocs\, and other early career researchers. This year\, the organizational committee is co-chaired by Alam García-Heredia\, a postdoc in Alan Grossman’s lab at MIT\, and Shailab Shrestha\, a graduate student in Aimee Shen’s lab at Tufts.
URL:https://carb-x.org/event/boston-bacterial-meeting-2023/
LOCATION:Harvard Science Center
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230615T080000
DTEND;TZID=America/New_York:20230619T170000
DTSTAMP:20260403T180220
CREATED:20230419T193615Z
LAST-MODIFIED:20230419T193817Z
UID:7463-1686816000-1687194000@carb-x.org
SUMMARY:ASM Microbe 2023
DESCRIPTION:Join thousands of scientists\, researchers and healthcare professionals in your field\, who are all traveling to Houston\, TX from June 15-19 for the largest microbial sciences gathering in the world! Andy Weir\, John Nkengasong and Edward Holmes are just some of the world-renowned speakers lined up in ASM Microbe’s cutting-edge scientific program. \nPlus\, do you have late-breaking research? There is still time to join our robust scientific program! Emerging Abstract Submissions Opens April 4. Don’t miss the opportunity to present your research and learn about the latest science from experts and leaders in your field. \nASM Microbe 2023 will cover: \n\nDisaster Microbiology.\nEmerging Infections – What is the Next pandemic? (Focus on Nipah and Marburg).\nNatural Product Discovery and Synthesis.\nThe Next Generation Antifungal Agents: Clinical Application and Resistance.\nCombating the Climate Crisis with Critters: Microbial Carbon Capture.\nPowering the Future: Applied Microbiology in the Energy Industry.\nEquity and Access in Laboratory Diagnostics.\nMicrobiome Management in a Changing World.\nNew Perspectives on Phage Therapy to Treat Multidrug Resistant Infections.\nBeyond Academia: Fulfilling Microbiology Careers Outside the Tenure Track.\nThe Perks of Being Squishy: Archaea as a Skillful Mechanoresponsive Machine.\nWhat is the Microbiota Really Doing in Neuroinflammatory Diseases?\nAnd so much more!
URL:https://carb-x.org/event/asm-microbe-2023/
LOCATION:George R. Brown Convention Center\, Houston\, TX
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230813T080000
DTEND;TZID=America/New_York:20230817T170000
DTSTAMP:20260403T180220
CREATED:20230419T194204Z
LAST-MODIFIED:20230419T194204Z
UID:7466-1691913600-1692291600@carb-x.org
SUMMARY:ACS Fall Meeting - The Future of Antibiotic Drug Discovery
DESCRIPTION:Where thousands of chemistry professionals meet to share ideas and advance scientific and technical knowledge.
URL:https://carb-x.org/event/acs-fall-meeting-the-future-of-antibiotic-drug-discovery/
LOCATION:San Francisco\, CA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230907T080000
DTEND;TZID=America/New_York:20230908T170000
DTSTAMP:20260403T180220
CREATED:20221108T182939Z
LAST-MODIFIED:20221108T182939Z
UID:6996-1694073600-1694192400@carb-x.org
SUMMARY:World AMR Congress 2023
DESCRIPTION:THE WORLD’S LARGEST AMR CONFERENCE FOR ALL STAKEHOLDERS COMBATING ANTI-MICROBIAL RESISTANCE
URL:https://carb-x.org/event/world-amr-congress-2023/
LOCATION:Pennsylvania Convention Center\, Philadelphia\, PA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230919T080000
DTEND;TZID=America/New_York:20230922T170000
DTSTAMP:20260403T180220
CREATED:20221108T183119Z
LAST-MODIFIED:20221108T183119Z
UID:6999-1695110400-1695402000@carb-x.org
SUMMARY:2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
DESCRIPTION:The 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance is scheduled to take place Sept. 19-22\, 2023 in Boston\, Mass.  \nCo-sponsored by ASM and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID)\, this multidisciplinary meeting will highlight the challenges\, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.
URL:https://carb-x.org/event/2023-asm-escmid-joint-conference-on-drug-development-to-meet-the-challenge-of-antimicrobial-resistance/
LOCATION:Boston\, MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231005T130000
DTEND;TZID=America/New_York:20231005T140000
DTSTAMP:20260403T180220
CREATED:20230828T190620Z
LAST-MODIFIED:20230830T201404Z
UID:7761-1696510800-1696514400@carb-x.org
SUMMARY:Canada Webinar
DESCRIPTION:You are invited to an exclusive webinar for Canada by CARB-X on Thursday\, Oct. 5th at 1pm Eastern. This webinar will highlight the importance of antibacterial R&D\, provide an overview of CARB-X\, and describe how Canadian organizations and individuals may work with CARB-X in the future\, including receiving financial\, scientific\, regulatory and business support. The presenters will be Richard Alm\, the Chief Scientist of CARB-X\, and Rich Lawson\, a member of the CARB-X executive team. There will be approximately 30 minutes of presentation and then time for questions and answers.  \nPlease click here to register.
URL:https://carb-x.org/event/canada-webinar/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231011T080000
DTEND;TZID=America/New_York:20231015T170000
DTSTAMP:20260403T180221
CREATED:20230725T135450Z
LAST-MODIFIED:20230725T135450Z
UID:7661-1697011200-1697389200@carb-x.org
SUMMARY:ID Week 2023
DESCRIPTION:IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA)\, Society for Healthcare Epidemiology of America (SHEA)\, the HIV Medicine Association (HIVMA)\, the Pediatric Infectious Diseases Society (PIDS)\, and the Society of Infectious Diseases Pharmacists (SIDP).
URL:https://carb-x.org/event/id-week-2023/
LOCATION:Boston Convention Center\, 415 Summer St\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231015T080000
DTEND;TZID=America/New_York:20231017T170000
DTSTAMP:20260403T180221
CREATED:20221108T182804Z
LAST-MODIFIED:20221108T182804Z
UID:6994-1697356800-1697562000@carb-x.org
SUMMARY:World Health Summit 2023
DESCRIPTION:The World Health Summit is the unique international strategic forum for global health. Held annually in Berlin\, it brings together stakeholders from politics\, science\, the private sector\, and civil society from around the world to set the agenda for a healthier future by inspiring innovative solutions for better health and well-being for all. \nThe World Health Summit was founded in 2009 on the occasion of the 300th anniversary of Charité – Universitätsmedizin Berlin. It is traditionally held under the patronage of the German Chancellor\, the French President\, the President of the European Commission\, and the Director-General of the World Health Organization (WHO). President of the World Health Summit is Axel R. Pries\, Dean of Charité. \nIn addition to the World Health Summit in Berlin\, there are annual Regional Meetings and regular Expert Meetings around the world. These meetings are organized by the M8 Alliance\, the academic backbone of the World Health Summit.
URL:https://carb-x.org/event/world-health-summit-2023/
LOCATION:Berlin\, Germany
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231130T080000
DTEND;TZID=America/New_York:20231201T170000
DTSTAMP:20260403T180221
CREATED:20230725T140306Z
LAST-MODIFIED:20230725T140306Z
UID:7663-1701331200-1701450000@carb-x.org
SUMMARY:BSAC Winter Conference 2023
DESCRIPTION:Infection 2023: BSAC Winter Conference – Addressing AMR across the tightrope of politics\, policy and practice
URL:https://carb-x.org/event/bsac-winter-conference-2023/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240214T080000
DTEND;TZID=America/New_York:20240216T170000
DTSTAMP:20260403T180221
CREATED:20230725T140928Z
LAST-MODIFIED:20230725T174830Z
UID:7667-1707897600-1708102800@carb-x.org
SUMMARY:Lorne Infection & Immunity 2024
DESCRIPTION:The Lorne Infection and Immunity Conference brings together scientists\, students\, health care and industry from multiple disciplines with a shared interest in infection and immunity research. \nRegistrations are open and abstracts are now being accepted. \nECR awards\, subsidised student registrations\, an amazing speaker list\, networking and social events\, and the return to our face-to-face meeting format combined with the advantages of online participation\, mean participation is accessible to everyone and there is every reason to join in. \nSee below for links to register and for more information. \n2024 THEMES\nHost-pathogen interactions \nMolecular basis of infectious diseases \nInnate immunity \nAdaptive immunity \nAdvances in immunotherapy vaccines and clinical translation \nNew solutions for antimicrobial resistance \nEmerging infectious diseases and global health
URL:https://carb-x.org/event/lorne-infection-immunity-2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240306T080000
DTEND;TZID=America/New_York:20240307T170000
DTSTAMP:20260403T180221
CREATED:20230725T140448Z
LAST-MODIFIED:20230725T140448Z
UID:7665-1709712000-1709830800@carb-x.org
SUMMARY:8th AMR Conference
DESCRIPTION:The #AMRconference is a platform for SMEs\, start-ups\, big pharma\, academia\, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market. \nThe conference is the one-stop shop to catch up with the latest trends in the development of AMR products\, by covering scientific\, regulatory\, financial and policy topics. Besides high-level talks\, the conference is a great place to network and exchange views on innovative technologies\, development paths and alternative business models with your peers. The conference also offers a partnering platform to facilitate interactions. \nThe 7th edition covered the whole innovation value chain\, including scientific breakthrough\, preclinical and clinical development\, but also financial topics such as public funding for R&D\, market incentive and investors’ perspective. Specific sessions were also dedicated to antimicrobials in the environment\, diagnostics\, antifungals\, biologics and anti-tuberculosis drug combinations. There was a special focus on India and how the country is getting prepared to provide global solutions against AMR. Among other highlights were a start-up competition\, hosted by the pharma-backed incubator INCATE\, and a poster prize. \n\n\n\n\n\n\n\n\n\n\n\n\nThe AMR Conference is jointly organized by BEAM Alliance and bamconn GmbH. \nThe BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015\, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance gathers more than 70 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. BEAM Alliance carries the voice of SMEs to support policies and incentives in antimicrobial research and development in Europe. \nbamconn GmbH was established in November 2022 as a spin-off of BIOCOM AG and continues its entire event management as an independent company. It is built on more than 15 years of experience in the planning\, organization and implementation of scientific events and exhibitions. The portfolio covers the entire spectrum from small workshops with 20 participants to multi-day international conferences for up to 2\,000 people as well as exhibitions on the topic of bioeconomy throughout Europe. Customers for whom the bamconn team worked so far are companies\, research institutions\, associations and federal ministries as well as subordinate authorities and EU-funded projects.
URL:https://carb-x.org/event/8th-amr-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240313T080000
DTEND;TZID=America/New_York:20240315T170000
DTSTAMP:20260403T180221
CREATED:20240223T223718Z
LAST-MODIFIED:20240223T223718Z
UID:8213-1710316800-1710522000@carb-x.org
SUMMARY:Antimicrobial Resistance - Genomes\, Big Data and Emerging Technologies
DESCRIPTION:Antimicrobial resistance (AMR) is a major challenge in our globalised world\, and tackling it will take the combined resources and effort of researchers working across different disciplines. Technical advances in recent years continue to expand our ability to collect vast amounts of genomic information on pathogens\, and a wealth of data is being collected in epidemiological and surveillance studies\, including on the socio-economic burden of AMR. \nOur 4th conference in this series will bring together basic researchers\, clinicians\, computer scientists\, and policymakers interested in pathogen genomics\, epidemiology\, surveillance\, and machine learning to explore the recent advances and current challenges of the field. \nThis year’s programme will once again focus on genomic evidence and how to implement it in clinical practice and policy for AMR control. The meeting will highlight the advances in machine learning\, AI and computational tools to predict AMR. We will also discuss how to build an international genomics infrastructure to tackle AMR and emerging lessons from other global public health issues. \nThis conference will be a hybrid meeting – with onsite or virtual attendance. In addition to invited talks\, the programme will include short oral presentations selected from abstracts\, posters\, poster pitches and networking breaks for further discussion.
URL:https://carb-x.org/event/antimicrobial-resistance-genomes-big-data-and-emerging-technologies/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240315T143000
DTEND;TZID=Europe/Brussels:20240315T160000
DTSTAMP:20260403T180221
CREATED:20240222T165809Z
LAST-MODIFIED:20240222T165809Z
UID:8211-1710513000-1710518400@carb-x.org
SUMMARY:COMBINE Webinar | Development of Target Product Profiles for Antibiotics
DESCRIPTION:Calling all #healthcare innovators! 📢 Don’t miss out on the IMI COMBINE project webinar discussing Target Product Profiles for #antibiotic development. Join industry leaders from CARB-X\, Evotec\, and GSK on March 15\, 14:30 – 16:00 CET. \nDr. Erin Duffy\, Chief of R&D of CARB-X\, will be a panelist. \nTo register: https://limesurvey.biocom.de/index.php/191531?lang=en&newtest=Y \nFor more details on the webinar: https://amr-accelerator.eu/event/combine-webinar-on-developing-target-product-profiles-for-antibiotics/
URL:https://carb-x.org/event/combine-webinar-development-of-target-product-profiles-for-antibiotics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240317T080000
DTEND;TZID=America/New_York:20240322T170000
DTSTAMP:20260403T180221
CREATED:20240223T223851Z
LAST-MODIFIED:20240223T223851Z
UID:8215-1710662400-1711126800@carb-x.org
SUMMARY:Gordon Research Conference | Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis
DESCRIPTION:The New Antibacterial Discovery and Development GRC is a premier\, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research\, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide\, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities\, with lasting collaborations and friendships. In addition to premier talks\, the conference has designated time for poster sessions from individuals of all career stages\, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field. \n\nThe antibiotic resistance crisis is among us\, and with it\, the urgent need to tackle this global health threat has never been greater. Yet each step in the discovery and development process\, from target validation and inhibitor optimization to clinical trial design and product commercialization\, poses formidable challenges. The New Antibacterial Discovery and Development GCR will turn these challenges into opportunities to promote interdisciplinary innovation while addressing the global need for more effective antibiotic therapies. \nThe conference will offer a forum where participants of all backgrounds and career stages explore solutions to current bottlenecks in antibacterial drug development\, creating bridges between Academia\, Industry\, and Governments. Importantly\, the meeting will provide early career researchers and trainees ample networking opportunities with highly experienced leaders in a positive and inclusive environment. We hope to see you in Ventura!
URL:https://carb-x.org/event/gordon-research-conference-innovative-approaches-in-antibacterial-research-and-development-to-fight-the-antibiotic-resistance-crisis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240325T080000
DTEND;TZID=America/New_York:20240326T170000
DTSTAMP:20260403T180221
CREATED:20240322T195629Z
LAST-MODIFIED:20240322T195629Z
UID:8419-1711353600-1711472400@carb-x.org
SUMMARY:Novel Diagnostics for Infectious Diseases
DESCRIPTION:This two-day meeting will delve into common challenges shared by diagnostics developers. Through presentations and panel discussions\, attendees will explore topics such as Technologies and Challenges\, Regulatory and Adoption Challenges\, and Regulation and Policy Perspectives. \nThis workshop is co-organised and funded by Imperial College London’s Institute of Infection\, B2B2B Network\, London In Vitro Diagnostics Co-operative\, NIHR Biomedical Research Centre\, and DIAMONDS consortium. Funding is also provided by the UKRI IAA Healthy Society award and the Rosetrees Trust.  \n  \nBetsy Wonderly Trainor\, Alliance Director at CARB-X\, will be a speaker during the “Funding innovative diagnostics: Lessons learnt and roadmap to future impact” session.
URL:https://carb-x.org/event/novel-diagnostics-for-infectious-diseases/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240401T080000
DTEND;TZID=America/New_York:20240404T170000
DTSTAMP:20260403T180221
CREATED:20240223T224039Z
LAST-MODIFIED:20240223T224039Z
UID:8217-1711958400-1712250000@carb-x.org
SUMMARY:World Vaccine Congress
DESCRIPTION:R&D + STRATEGIC PARTNERING FOR THE GLOBAL VACCINE INDUSTRY \nThe World Vaccine Congress is the largest\, most established meeting dedicated to vaccines. \nFrom basic research to commercial manufacture\, this one meeting covers the whole vaccine value chain where science\, government and manufacturers all come together to create groundbreaking progress.
URL:https://carb-x.org/event/world-vaccine-congress-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240427T080000
DTEND;TZID=America/New_York:20240430T170000
DTSTAMP:20260403T180221
CREATED:20240223T224301Z
LAST-MODIFIED:20240223T224301Z
UID:8219-1714204800-1714496400@carb-x.org
SUMMARY:ECCMID 2024
DESCRIPTION:Embrace the best of both worlds at ECCMID 2024 taking place 27-30 April 2024 in Barcelona\, Spain! Engage in a cutting-edge medical congress\, while experiencing the city’s irresistible charm. Barcelona offers the perfect fusion of knowledge and adventure. \nECCMID 2024 will follow the successful format introduced in 2022\, offering a comprehensive hybrid congress. While we encourage the majority of our faculty\, abstract presenters\, and attendees\, to participate on-site and benefit from the scientific\, educational and networking experiences\, provided by ECCMID\, our seamless hybrid solution allows remote attendance for those unable to travel for any reason. Whether you come and join us in Barcelona\, Spain or sign in online from your living room or office\, you will be able to fully enjoy what ECCMID 2024 has to offer.
URL:https://carb-x.org/event/eccmid-2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240521T080000
DTEND;TZID=America/New_York:20240524T170000
DTSTAMP:20260403T180221
CREATED:20240223T224506Z
LAST-MODIFIED:20240223T224506Z
UID:8221-1716278400-1716570000@carb-x.org
SUMMARY:5th H3D Symposium
DESCRIPTION:We are excited to announce that the 5th H3D Foundation Symposium will be taking place from 21 to 24 May 2024 at the Radisson Blu Mosi-Oa-Tunya Livingstone Resort in Zambia. \nThe symposium is a pinnacle event for H3D\, following the success of the previous four symposia held in Cape Town and Livingstone. \nThe 5th H3D Symposium will be held at the prestigious Radisson Blu Mosi-Oa-Tunya Livingstone Resort in Zambia\, providing a captivating backdrop near the magnificent Victoria Falls on the banks of the Zambezi River. \nThis symposium will focus on the theme “Emerging Treatments for Drug-Resistant Infections of Bacterial and Mycobacterial Origin\,” addressing the pressing challenge of antimicrobial resistance (AMR). \nWhat to expect:  \n\nFace-to-face exposure to more than 150 local\, regional\, and international delegates from tertiary institutions and the pharmaceutical industry\, scientists\, and researchers with a specific interest in TB\, AMR & NTDS.\nAn innovative programme comprising instructional course lectures (ICLs)\, the latest research\, keynote lectures\, oral and rapid-fire sessions and ePosters.\nInteraction between high-profile\, distinguished international scientists and diverse participants\, including postgraduate students and postdoctoral fellows.\nA platform to present your latest research\, product development\, science\, and capabilities to a global audience.\nProvides your company and your products visibility.\n\nRegister to attend \nSecure your spot and participate in this exceptional event by registering online today!
URL:https://carb-x.org/event/5th-h3d-symposium/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240603T080000
DTEND;TZID=America/New_York:20240604T170000
DTSTAMP:20260403T180221
CREATED:20240222T160310Z
LAST-MODIFIED:20240222T160310Z
UID:8207-1717401600-1717520400@carb-x.org
SUMMARY:Boston Bacterial Meeting 2024
DESCRIPTION:The meeting will be held at Boston University at the George Sherman Union\, 775 Commonwealth Ave\, Boston. \nThe keynote address for BBM 2024 will be delivered by Dr. Joe Bondy-Denomy\, UCSF. Joe Bondy-Denomy is an Associate Professor at UCSF. Dr. Bondy-Denomy earned his PhD from University of Toronto working in the lab of Alan Davidson. During this time\, he studied the interactions between bacteriophages and Pseudomonas aeruginosa. He became especially interested in the role of bacterial CRISPR/Cas systems in defending against phages and the strategies phages use to overcome CRISPR/Cas systems. Specifically\, he found that phages encode anti-CRISPR proteins that block the activity of CRISPR/Cas systems. He started his lab at UCSF in 2015 as a Sandler Faculty Fellow with a focus on understanding the interplay between bacterial CRISPR/Cas systems and phage anti-CRISPRs. He was promoted to Assistant Professor in 2017 and Associate Professor in 2020.  His lab’s research has revealed fascinating insight into the interactions between bacteria and phages including discoveries of countless anti-CRISPR proteins\, elucidation of the mechanisms through which CRISPR/Cas systems and anti-CRISPR proteins are regulated\, and more recently investigation of novel mechanisms of phage defense and phage evasion. His lab has used understanding of CRISPR/Cas systems to improve methods for editing the genomes of bacteria and phages hoping that this will ultimately to support the development of phage therapies. \nAbout BBM \nBBM was founded in 1995 by two postdocs from Richard Losick’s lab at Harvard\, Kit Pogliano and Karen McGovern\, with the goal of bringing bacteriologists from the greater Boston area together to present their work and share ideas. BBM\, now in its 30th year\, has proven to be a vibrant meeting\, attended not only by bacteriologists from the Boston area but from all over the country. Keeping with its roots\, the conference is being planned and organized by a committee of students\, postdocs\, and other early career researchers. This year\, the organizational committee is co-chaired by Molly Sargen\, a graduate student in Sophie Helaine’s lab at Harvard Medical School\, and Laurent Dubois\, a graduate student in Tom Bernhardt’s lab at Harvard Medical School.
URL:https://carb-x.org/event/boston-bacterial-meeting-2024/
LOCATION:Boston University
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240603T080000
DTEND;TZID=America/New_York:20240606T170000
DTSTAMP:20260403T180221
CREATED:20240223T224704Z
LAST-MODIFIED:20240223T224704Z
UID:8223-1717401600-1717693200@carb-x.org
SUMMARY:BIO San Diego
DESCRIPTION:The BIO International Convention is the largest and most comprehensive event for biotechnology\, representing the full ecosystem of biotech with over 20\,000 industry leaders from across the globe. \nWhether you work at a public pharmaceutical company\, biotech startup\, academia\, non-profits\, and government or are a researcher\, business development professional or investor\, BIO is where you’ll make valuable connections and build relationships. Our proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners\, schedule and accept meetings.
URL:https://carb-x.org/event/bio-san-diego/
END:VEVENT
END:VCALENDAR